Total Debt
$302K
Net Debt
-$452.1M
Enliven Therapeutics, Inc. currently has $302K in total debt. Net debt is -$452.1M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
ELVN • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.00 | 0.45 | -0.45Net Cash | 0.46 | 0.1% |
| 2025-12-31 | 0.00 | 0.46 | -0.46Net Cash | 0.48 | 0.1% |
| 2025-09-30 | 0.00 | 0.48 | -0.48Net Cash | 0.49 | 0.1% |
| 2025-06-30 | 0.00 | 0.49 | -0.49Net Cash | 0.50 | 0.1% |
| 2025-03-31 | 0.00 | 0.29 | -0.29Net Cash | 0.30 | 0.1% |
| 2024-12-31 | 0.00 | 0.31 | -0.31Net Cash | 0.33 | 0.0% |
| 2024-09-30 | 0.00 | 0.29 | -0.29Net Cash | 0.31 | 0.0% |
| 2024-06-30 | 0.00 | 0.31 | -0.31Net Cash | 0.33 | 0.1% |
| 2024-03-31 | 0.00 | 0.32 | -0.32Net Cash | 0.34 | 0.1% |
| 2023-12-31 | 0.00 | 0.25 | -0.25Net Cash | 0.27 | 0.1% |
| 2023-09-30 | 0.00 | 0.26 | -0.26Net Cash | 0.27 | 0.1% |
| 2023-06-30 | 0.00 | 0.28 | -0.28Net Cash | 0.29 | 0.1% |
| 2023-03-31 | 0.00 | 0.29 | -0.29Net Cash | 0.30 | 0.1% |
| 2022-12-31 | 0.00 | 0.08 | -0.08Net Cash | 0.08 | 0.4% |
| 2022-09-30 | 0.00 | 0.09 | -0.09Net Cash | 0.09 | 0.4% |
| 2022-06-30 | 0.00 | 0.06 | -0.06Net Cash | 0.06 | 0.7% |
| 2022-03-31 | 0.00 | 0.07 | -0.07Net Cash | 0.08 | 3.0% |
| 2021-12-31 | 0.00 | 0.11 | -0.11Net Cash | 0.11 | 0.1% |
| 2021-09-30 | 0.00 | 0.10 | -0.10Net Cash | 0.11 | 0.7% |
| 2021-06-30 | 0.00 | 0.07 | -0.07Net Cash | 0.07 | 1.1% |
| 2021-03-31 | 0.00 | 0.08 | -0.07Net Cash | 0.08 | 1.0% |
| 2020-12-31 | 0.00 | 0.09 | -0.09Net Cash | 0.09 | 0.0% |
| 2020-09-30 | 0.00 | 0.10 | -0.10Net Cash | 0.10 | 0.0% |
| 2020-06-30 | 0.00 | 0.11 | -0.11Net Cash | 0.11 | 0.0% |
| 2020-03-31 | 0.00 | 0.11 | -0.11Net Cash | 0.11 | 0.0% |
| 2019-12-31 | 0.00 | 0.03 | -0.03Net Cash | 0.03 | 0.0% |